Antisense oligonucleotides against collagen-binding stress protein HSP47 suppress peritoneal fibrosis in rats. 2003

Tomoya Nishino, and Masanobu Miyazaki, and Katsushige Abe, and Akira Furusu, and Yoko Mishima, and Takashi Harada, and Yoshiyuki Ozono, and Takehiko Koji, and Shigeru Kohno
Second Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki, Japan.

BACKGROUND Peritoneal fibrosis is a serious complication in patients on continuous ambulatory peritoneal dialysis (CAPD), but the molecular mechanism of this process remains unclear. Heat shock protein 47 (HSP47), a collagen-specific molecular chaperone, is essential for biosynthesis and secretion of collagen molecules, and is expressed in the tissue of human peritoneal fibrosis. In the present study, we examined the effect of HSP47 antisense oligonucleotides (ODNs) on the development of experimental peritoneal fibrosis induced by daily intraperitoneal injections of chlorhexidine gluconate (CG). METHODS HSP47 antisense or sense ODNs were injected simultaneously with CG from day 14, after injections of CG alone. Peritoneal tissue was dissected out 28 days after CG injection. The expression patterns of HSP47, type I and type III collagen, alpha-smooth muscle actin (alpha-SMA), as a marker of myofibroblasts, ED-1 (as a marker of macrophages), and factor VIII were examined by immunohistochemistry. RESULTS In rats treated with CG alone, the submesothelial collagenous compact zone was thickened, where the expression levels of HSP47, type I and type III collagen and alpha-SMA were increased. Marked macrophage infiltration was also noted and the number of vessels positively stained for factor VIII increased in the CG-treated group. Treatment with antisense ODNs, but not sense ODNs, abrogated CG-induced changes in the expression of HSP47, type I and III collagen, alpha-SMA, and the number of infiltrating macrophages and vessels. CONCLUSIONS Our results indicate the involvement of HSP47 in the progression of peritoneal fibrosis and that inhibition of HSP47 expression might merit further clinical investigation for the treatment of peritoneal fibrosis in CAPD patients.

UI MeSH Term Description Entries
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D008297 Male Males
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D009130 Muscle, Smooth Unstriated and unstriped muscle, one of the muscles of the internal organs, blood vessels, hair follicles, etc. Contractile elements are elongated, usually spindle-shaped cells with centrally located nuclei. Smooth muscle fibers are bound together into sheets or bundles by reticular fibers and frequently elastic nets are also abundant. (From Stedman, 25th ed) Muscle, Involuntary,Smooth Muscle,Involuntary Muscle,Involuntary Muscles,Muscles, Involuntary,Muscles, Smooth,Smooth Muscles
D010537 Peritoneum A membrane of squamous EPITHELIAL CELLS, the mesothelial cells, covered by apical MICROVILLI that allow rapid absorption of fluid and particles in the PERITONEAL CAVITY. The peritoneum is divided into parietal and visceral components. The parietal peritoneum covers the inside of the ABDOMINAL WALL. The visceral peritoneum covers the intraperitoneal organs. The double-layered peritoneum forms the MESENTERY that suspends these organs from the abdominal wall. Parietal Peritoneum,Peritoneum, Parietal,Peritoneum, Visceral,Visceral Peritoneum,Parametrium,Parametriums
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D005355 Fibrosis Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury. Cirrhosis,Fibroses
D006360 Heat-Shock Proteins Proteins which are synthesized in eukaryotic organisms and bacteria in response to hyperthermia and other environmental stresses. They increase thermal tolerance and perform functions essential to cell survival under these conditions. Stress Protein,Stress Proteins,Heat-Shock Protein,Heat Shock Protein,Heat Shock Proteins,Protein, Stress
D000199 Actins Filamentous proteins that are the main constituent of the thin filaments of muscle fibers. The filaments (known also as filamentous or F-actin) can be dissociated into their globular subunits; each subunit is composed of a single polypeptide 375 amino acids long. This is known as globular or G-actin. In conjunction with MYOSINS, actin is responsible for the contraction and relaxation of muscle. F-Actin,G-Actin,Actin,Isoactin,N-Actin,alpha-Actin,alpha-Isoactin,beta-Actin,gamma-Actin,F Actin,G Actin,N Actin,alpha Actin,alpha Isoactin,beta Actin,gamma Actin

Related Publications

Tomoya Nishino, and Masanobu Miyazaki, and Katsushige Abe, and Akira Furusu, and Yoko Mishima, and Takashi Harada, and Yoshiyuki Ozono, and Takehiko Koji, and Shigeru Kohno
August 1998, Laboratory investigation; a journal of technical methods and pathology,
Tomoya Nishino, and Masanobu Miyazaki, and Katsushige Abe, and Akira Furusu, and Yoko Mishima, and Takashi Harada, and Yoshiyuki Ozono, and Takehiko Koji, and Shigeru Kohno
July 2007, Toxicology,
Tomoya Nishino, and Masanobu Miyazaki, and Katsushige Abe, and Akira Furusu, and Yoko Mishima, and Takashi Harada, and Yoshiyuki Ozono, and Takehiko Koji, and Shigeru Kohno
September 2003, Archives of oral biology,
Tomoya Nishino, and Masanobu Miyazaki, and Katsushige Abe, and Akira Furusu, and Yoko Mishima, and Takashi Harada, and Yoshiyuki Ozono, and Takehiko Koji, and Shigeru Kohno
March 1996, DNA and cell biology,
Tomoya Nishino, and Masanobu Miyazaki, and Katsushige Abe, and Akira Furusu, and Yoko Mishima, and Takashi Harada, and Yoshiyuki Ozono, and Takehiko Koji, and Shigeru Kohno
December 1994, The Journal of biological chemistry,
Tomoya Nishino, and Masanobu Miyazaki, and Katsushige Abe, and Akira Furusu, and Yoko Mishima, and Takashi Harada, and Yoshiyuki Ozono, and Takehiko Koji, and Shigeru Kohno
December 1998, Cell stress & chaperones,
Tomoya Nishino, and Masanobu Miyazaki, and Katsushige Abe, and Akira Furusu, and Yoko Mishima, and Takashi Harada, and Yoshiyuki Ozono, and Takehiko Koji, and Shigeru Kohno
December 1994, The Journal of clinical investigation,
Tomoya Nishino, and Masanobu Miyazaki, and Katsushige Abe, and Akira Furusu, and Yoko Mishima, and Takashi Harada, and Yoshiyuki Ozono, and Takehiko Koji, and Shigeru Kohno
April 1996, The Journal of cell biology,
Tomoya Nishino, and Masanobu Miyazaki, and Katsushige Abe, and Akira Furusu, and Yoko Mishima, and Takashi Harada, and Yoshiyuki Ozono, and Takehiko Koji, and Shigeru Kohno
December 2019, Biomolecules,
Tomoya Nishino, and Masanobu Miyazaki, and Katsushige Abe, and Akira Furusu, and Yoko Mishima, and Takashi Harada, and Yoshiyuki Ozono, and Takehiko Koji, and Shigeru Kohno
January 1995, In vivo (Athens, Greece),
Copied contents to your clipboard!